Proteomics is the large-scale study of proteins. Mass spectrometry (MS) is one of the most informative techniques for analyzing proteins. Proteomics-based MS examines biological changes in diseases. It also identifies potential biomarker candidates in early disease stages, enabling the diagnosis, prognosis, and evaluation of therapeutic efficacy. Developing efficient and high-throughput proteomics techniques enables comprehensive exploration of the human plasma proteome. In this study, we compared the performance of various MS instruments and software tools for analyzing data-independent acquisition plasma proteomics data. We employed a “mixed species” approach, spiking three different amounts of Escherichia coliproteins into a constant amount of human plasma proteins to evaluate various LC–MS run length and data analysis workflows (DIA-NN and Spectronaut) for their ability to detect differential abundance. Assessing the power of the method to detect differences provides a more informative evaluation of workflow performance than relying solely on CVs. Our research shows that the ZenoTOF 7600 MS workflow, combined with DIA-NN in library mode, was most effective at detecting true-positive changes in protein abundance in our spiked samples. DIA-NN in library mode using the 21 min gradient method outperformed Spectronaut in detecting true-positive change. These results hold promise for detecting differentially abundant proteins in plasma.
No takes yet. Share an insight, caveat, or question.
Alharbi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: